✦ LIBER ✦

615 - Comparative study of intravesical instillation of epirubicin, BCG, or BCG + INH in intermediate and high risk pTa-pT1 papillary carcinoma of the urinary bladder. First results of EORTC 30911

✍ Scribed by A.v.d. Meijden; M. Brausi; W. Höltl; D. Mack; R.v. Velthoven; F. Calais da Silva; R. Sylvester; C. de Balincourt

Book ID: 117664863
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 255 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)85172-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LONG-TERM EFFICACY RESULTS OF EORTC GU G

LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTEGUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER

✍ R.J. Sylvester; M.A. Brausi; W. Hoeltl; P.H. Powell; P. Whelan; T. Gorlia; T.M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

A randomised prospective study comparing

A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder

✍ Witjes, J.A.; Meijden, A.P.M.v.d.; Witjes, W.P.J.; Doesburg, W.; Schaafsma, H.E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 655 KB

LONG-TERM EFFICACY RESULTS OF EORTC GU G

LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTE- GUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 BLADDER CARCINOMA

✍ Sylvester, Richard; Brausi, Maurizio; Hoeltl, Wolfgang; Powell, Philip; Whelan, 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 138 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ R.J. Sylvester; W. Oosterlinck; M.A. Brausi; W.J. Kirkels; F. Calais Da Silva; T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ Sylvester, Richard; Oosterlinck, Willem; Brausi, Maurizio; Kirkels, Wim J; Da Si 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 146 KB

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB